Inventor · disambiguated record
Jason M. Lajoie
Also filed as: LAJOIE JASON · LAJOIE JASON M · LAJOIE JASON MICHAEL
8 granted patents·5 pending applications·58 citations·filing 2018–2023
87Inventor score
Top patents by PatentIndex Score
13 records- 0196US10716851B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted Jul 21, 2020·10 cites·5 claims
- 0296US10350292B1Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Jul 16, 2019·12 cites·28 claims
- 0396US10279039B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·10 cites·20 claims
- 0496US10279038B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·11 cites·16 claims
- 0596US10279040B1Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·10 cites·20 claims
- 0695US10434175B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Oct 8, 2019·5 cites·20 claims
- 0787US2024181050A1Agonist antibodies that bind human cd137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0878US2020046833A1Agonist antibodies that bind human cd137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 0975US11752207B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 1053US2024252641A1Compositions and methods for tcr reprogramming using cd70 specific fusion proteinsTCR2 THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1152US12371468B2Variable lymphocyte receptors that target the blood brain barrier and methods of useWISCONSIN ALUMNI RES FOUND·Filed 2020·Granted Jul 29, 2025·0 cites·22 claims
- 1252US2020079867A1Compositions and methods for enhancing the killing of target cells by nk cellsCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 1345US2020109195A1Compositions and methods for enhancing the killing of target cells by nk cellsCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason M. Lajoie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →